HUMAN TELOMERASE REVERSE TRANSCRIPTASE AS A CLASS-II RESTRICTED TUMOR-ASSOCIATED ANTIGEN

摘要

The present invention relates to the identification of MHC-II hTRT restricted epitopes and the use of these identified epitopes to elicit an immune response against the epitope. More particularly, the identified epitopes are administered to a subject to treat hyperproliferative diseases.